Health / Startups / Universities

This JHU startup is working on a treatment to prevent Alzheimer’s

AgeneBio received a $7 million grant from the National Institutes of Health to begin a new round of drug trials.

The hands of an Alzheimer's patient. (Photo by Flickr user Ann, used under a Creative Commons license)

A Johns Hopkins startup received a federal grant to enter trials of its treatment for a brain disease that often precedes Alzheimer’s disease.
AgeneBio and Johns Hopkins received a five-year grant from the National Institutes of Health that is projected to total $7.2 million for Phase 3 trials of the therapeutic, called AGB101. If successful, the drug could be the first therapeutic to prevent or delay Alzheimer’s by curing a brain condition that is typically a precursor to the debilitating elderly disorder.
The treatment focuses on a disease known as aMCI. It’s been identified as the earliest point to diagnose a pre-dementia state, and often develops into full-blown Alzheimer’s within a few years. About 5.2 million Americans suffer from the disease.

The therapeutic, which is a low-dose version of a drug used to treat epilepsy, treats overactivity in the hippocampus portion of the brain that is associated with aMCI.
A Phase 2 trial restored brain function and memory in patients. Phase 3 trials, which could last up to two years, are projected to start early next year. That final phase of trials before the company submits to the FDA will involve hundreds of patients.
The treatment grew out of research by Hopkins neuroscientist Michela Gallagher, who founded AgeneBio. The company’s offices are in in Johns Hopkins’ Eastern campus on 33rd Street in Waverly.

Companies: Johns Hopkins University

Before you go...

Please consider supporting to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

3 ways to support our work:
  • Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
  • Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
  • Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
The journalism fund Preferred partners Our services

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!


Inside Maryland’s latest effort to support emerging businesses

A Baltimore entrepreneur’s new platform aims to topple tech silos

As a returning citizen, she experienced tech overload. Now she’s fighting to end the digital divide

This Week in Jobs: The kernel of a new career is in these 20 tech opportunities

Technically Media